Onconetix, Inc. Fair Value of Assets Acquired
Onconetix, Inc. (ONCO) reported Fair Value of Assets Acquired of $1.87 million for the 9-month period ending 2024-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueOfAssetsAcquired · last filed 2025-11-13
- Onconetix, Inc. fair value of assets acquired for the quarter ending 2023-12-31 was $0.00.
- Onconetix, Inc. fair value of assets acquired for the quarter ending 2022-12-31 was $0.00.
- Onconetix, Inc. fair value of assets acquired for fiscal 2023 was $2.61M, a 203.77% increase from fiscal 2022.
- Onconetix, Inc. fair value of assets acquired for fiscal 2022 was $860.20K.
| Period end | Fair Value of Assets Acquired 3 month | Fair Value of Assets Acquired 9 month | Fair Value of Assets Acquired 12 month |
|---|---|---|---|
| 2024-09-30 | $1.87M 10-Q · filed 2025-11-13 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-02 | $2.61M 10-K · filed 2025-06-02 | |
| 2023-09-30 | $2.61M 10-Q · filed 2024-12-10 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-11 | $860.20K 10-K · filed 2024-04-11 | |
| 2022-09-30 | $860.20K 10-Q · filed 2023-11-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |